MCCLENNEN PETER A 4
4 · Teladoc Health, Inc. · Filed Jul 19, 2019
Insider Transaction Report
Form 4
MCCLENNEN PETER A
President
Transactions
- Sale
Common Stock
2019-07-17$69.10/sh−7,829$540,984→ 7,830 total - Sale
Common Stock
2019-07-15$70.99/sh−13,753$976,325→ 15,659 total - Sale
Common Stock
2019-07-17$69.07/sh−7,830$540,818→ 0 total - Exercise/Conversion
Common Stock
2019-07-15+29,412→ 29,412 total - Exercise/Conversion
Restricted Stock Units
2019-07-15−29,412→ 0 total→ Common Stock (29,412 underlying)
Footnotes (6)
- [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019.
- [F4]Represents the weighted average price of transactions ranging from $68.90 to $69.32. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- [F6]On July 14, 2017, the reporting person was was granted 58,824 restricted stock units, vesting in two equal annual installments beginning on July 14, 2018.